• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微血管和淋巴管密度高预示食管鳞癌患者预后不良。

High microvessel and lymphatic vessel density predict poor prognosis in patients with esophageal squamous cell carcinoma.

机构信息

Pathology, Shihezi University School of Medicine/The First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, China.

Department of Oncology, The First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, China.

出版信息

PeerJ. 2024 Sep 27;12:e18080. doi: 10.7717/peerj.18080. eCollection 2024.

DOI:10.7717/peerj.18080
PMID:39351370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11441385/
Abstract

BACKGROUND

Microangiogenesis and lymphangiogenesis are essential for tumor growth in the tumor microenvironment, contributing to tumor invasion and metastasis. Limited literature exists on these processes in esophageal squamous cell carcinoma (ESCC). Therefore, the purpose of this study is to explore the impacts of microangiogenesis and lymphangiogenesis on the occurrence, progression, and prognosis assessment of ESCC.

METHODS

Surgical specimens and paraffin-embedded human tissues were procured from ESCC patients, encompassing 100 ESCC tissues and 100 cancer-adjacent normal (CAN) tissues. CD34 and D2-40 were utilized as markers for microvessel endothelial cells and lymphatic vessel endothelial cells, respectively. Microvascular density (MVD) and lymphatic vessel density (LVD) were evaluated through immunohistochemical quantification.

RESULTS

We found that tumor tissues in ESCC patients had significantly higher MVD and LVD than cancer-adjacent normal (CAN) tissues. High MVD and LVD were associated with lymph node metastasis and advanced tumor clinical stages. Additionally, both high MVD and high LVD were strongly linked to poorer prognosis among cancer patients. Furthermore, a positive correlation was found between high MVD and high LVD ( < 0.05). The presence of these markers individually indicated a worse prognosis, with their combined assessment showcasing enhanced prognostic value.

CONCLUSIONS

Overall, the increased MVD and LVD indicates higher invasion and metastasis of ESCC, closely correlating with unfavorablefor poor prognosis of ESCC patients.

摘要

背景

微血管生成和淋巴管生成对于肿瘤微环境中的肿瘤生长至关重要,有助于肿瘤的侵袭和转移。关于食管鳞癌(ESCC)中这些过程的文献有限。因此,本研究旨在探讨微血管生成和淋巴管生成对 ESCC 发生、进展和预后评估的影响。

方法

从 ESCC 患者中获取手术标本和石蜡包埋的人类组织,包括 100 例 ESCC 组织和 100 例癌旁正常(CAN)组织。CD34 和 D2-40 分别用作微血管内皮细胞和淋巴管内皮细胞的标志物。通过免疫组化定量评估微血管密度(MVD)和淋巴管密度(LVD)。

结果

我们发现 ESCC 患者的肿瘤组织的 MVD 和 LVD 明显高于癌旁正常(CAN)组织。高 MVD 和 LVD 与淋巴结转移和晚期肿瘤临床分期有关。此外,高 MVD 和高 LVD 均与癌症患者的预后不良密切相关。此外,高 MVD 和高 LVD 之间存在正相关(<0.05)。这些标志物的存在均表明预后不良,其联合评估显示出更强的预后价值。

结论

总的来说,MVD 和 LVD 的增加表明 ESCC 的侵袭和转移更高,与 ESCC 患者的预后不良密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/3591b9e55e31/peerj-12-18080-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/8ae05328f94a/peerj-12-18080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/29804e2c315b/peerj-12-18080-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/95a9d2c85869/peerj-12-18080-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/802bd7c4393d/peerj-12-18080-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/3591b9e55e31/peerj-12-18080-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/8ae05328f94a/peerj-12-18080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/29804e2c315b/peerj-12-18080-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/95a9d2c85869/peerj-12-18080-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/802bd7c4393d/peerj-12-18080-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743c/11441385/3591b9e55e31/peerj-12-18080-g005.jpg

相似文献

1
High microvessel and lymphatic vessel density predict poor prognosis in patients with esophageal squamous cell carcinoma.微血管和淋巴管密度高预示食管鳞癌患者预后不良。
PeerJ. 2024 Sep 27;12:e18080. doi: 10.7717/peerj.18080. eCollection 2024.
2
The prognostic implications of microvascular density and lymphatic vessel density in esophageal squamous cell carcinoma: Comparative analysis between the traditional whole sections and the tissue microarray.食管鳞状细胞癌中微血管密度和淋巴管密度的预后意义:传统全切片与组织芯片的比较分析
Acta Histochem. 2014 May;116(4):646-53. doi: 10.1016/j.acthis.2013.12.003. Epub 2014 Jan 9.
3
Prognostic value of microvessel density in esophageal squamous cell carcinoma-a systematic review and meta-analysis.微血管密度在食管鳞癌中的预后价值:系统评价和荟萃分析。
Pathol Res Pract. 2021 Nov;227:153644. doi: 10.1016/j.prp.2021.153644. Epub 2021 Oct 5.
4
Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.肿瘤淋巴管生成与口腔鳞状细胞癌的淋巴结转移及临床病理参数相关。
Cancer. 2007 Sep 15;110(6):1287-94. doi: 10.1002/cncr.22900.
5
Aberrant Cyclin E and Hepatocyte Growth Factor Expression, Microvascular Density, and Micro-Lymphatic Vessel Density in Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌中细胞周期蛋白 E 和肝细胞生长因子表达、微血管密度和微淋巴管密度的改变。
Cancer Control. 2019 Jan-Dec;26(1):1073274819875736. doi: 10.1177/1073274819875736.
6
Lymphangiogenic and angiogenic microvessel density in chinese patients with gastric carcinoma: correlation with clinicopathologic parameters and prognosis.中国胃癌患者淋巴管生成和血管生成微血管密度:与临床病理参数及预后的相关性
Asian Pac J Cancer Prev. 2013;14(8):4549-52. doi: 10.7314/apjcp.2013.14.8.4549.
7
Vascular endothelial growth factors C and D and lymphangiogenesis at the early stage of esophageal squamous cell carcinoma progression.血管内皮生长因子C和D与食管鳞状细胞癌进展早期的淋巴管生成
Dis Esophagus. 2018 Aug 1;31(8). doi: 10.1093/dote/doy011.
8
Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.Podoplanin免疫反应性在食管鳞状细胞癌中的临床病理意义
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2361-71. eCollection 2014.
9
Prognostic value of blood and lymphatic vessel markers in tongue cancer: A systematic review.血液和淋巴管标志物在舌癌中的预后价值:系统评价。
Cancer Sci. 2019 Nov;110(11):3424-3433. doi: 10.1111/cas.14189. Epub 2019 Sep 30.
10
Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma.人类原发性散发性结直肠癌中的淋巴管生成和血管生成微血管密度
World J Gastroenterol. 2008 Jan 7;14(1):101-7. doi: 10.3748/wjg.14.101.

引用本文的文献

1
Differential Regulation of Angiogenesis, Lymphangiogenesis, and Neural Tissue in Normal and Inflamed Dental Pulp: Immunohistochemical Analysis.正常和炎症牙髓中血管生成、淋巴管生成及神经组织的差异调节:免疫组织化学分析
Diagnostics (Basel). 2025 Jul 19;15(14):1819. doi: 10.3390/diagnostics15141819.
2
Bioinformatics analysis and experimental validation of as a potential prognostic marker and therapeutic target for liver hepatocellular carcinoma.作为肝细胞癌潜在预后标志物和治疗靶点的生物信息学分析及实验验证
Biomol Biomed. 2025 Mar 7;25(4):925-939. doi: 10.17305/bb.2024.11246.

本文引用的文献

1
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis.鉴定用于宫颈癌预后评估的新基因特征:基于铜死亡相关血管生成和多组学分析
Cancer Cell Int. 2024 Jan 10;24(1):23. doi: 10.1186/s12935-023-03189-x.
3
Prostate Cancer Microvascular Routes: Exploration and Measurement Strategies.前列腺癌微血管路径:探索与测量策略
Life (Basel). 2023 Oct 9;13(10):2034. doi: 10.3390/life13102034.
4
Prognostic Nomogram for Lymph-Node Metastasis in Oral Squamous Cell Carcinoma (OSCC) Using Immunohistochemical Marker D2-40.使用免疫组化标志物D2-40的口腔鳞状细胞癌(OSCC)淋巴结转移预后列线图
Cancer Manag Res. 2023 Sep 1;15:929-936. doi: 10.2147/CMAR.S408772. eCollection 2023.
5
Evaluation of the prognostic significance of receptor tyrosine kinase-like orphan receptor 1 (ROR1) in lung carcinoma and its relation to lymphangiogenesis and epithelial mesenchymal transition.评估受体酪氨酸激酶样孤儿受体1(ROR1)在肺癌中的预后意义及其与淋巴管生成和上皮间质转化的关系。
Pathol Res Pract. 2023 Aug;248:154703. doi: 10.1016/j.prp.2023.154703. Epub 2023 Jul 20.
6
Angiogenic signaling pathways and anti-angiogenic therapy for cancer.血管生成信号通路与癌症的抗血管生成治疗。
Signal Transduct Target Ther. 2023 May 11;8(1):198. doi: 10.1038/s41392-023-01460-1.
7
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.《食管癌和食管胃交界癌,第2版,2023年,美国国立综合癌症网络肿瘤学临床实践指南》
J Natl Compr Canc Netw. 2023 Apr;21(4):393-422. doi: 10.6004/jnccn.2023.0019.
8
Lymphatic vessels in cancer.癌症中的淋巴管。
Physiol Rev. 2022 Oct 1;102(4):1837-1879. doi: 10.1152/physrev.00039.2021. Epub 2022 Jun 30.
9
Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy.食管鳞状细胞癌和腺癌的比较基因组分析:分子靶向治疗的新机遇
Acta Pharm Sin B. 2022 Mar;12(3):1054-1067. doi: 10.1016/j.apsb.2021.09.028. Epub 2021 Sep 30.
10
Co-expression of VEGF-C and survivin predicts poor prognosis in esophageal squamous cell carcinoma.血管内皮生长因子-C(VEGF-C)与生存素的共表达预示食管鳞状细胞癌预后不良。
Transl Cancer Res. 2021 Jan;10(1):210-222. doi: 10.21037/tcr-20-2498.